DOE-based Development of Liposome Encapsulated Delivery of Azithromycin for Wound Healing

References

[1] Ehrlich P. Collected Studies on Immunity-Vol-II. New York: Wiley, 1906: 442-447.

[2] Goldberg EP, ed. Targeted Drugs. New York: John Wiley and Sons, 1983.

[3] Gregoriadis G, Poste G, Senior J, Trouet A, eds. Receptor Mediated Targeting of Drugs, NATO Advanced Studies Institute Series A. New York: Plenum Press, 1985.

[4] Juliano RL, ed. Drug Delivery Systems: Characteristics and Biomedical Applications. New York: Oxford University Press, 1980.

[5] Poste G. Receptor Mediated Targeting of Drugs. In: Gregoriadis G, Poste G, Senior J, Trouet A, eds., NATO Advanced Studies Institute Series A, New York: Plenum, 1985: 427-439.

[6] Gieringer DH. The safety and efficacy of new drug approval. Cato J 1985; 5: 177–201.

[7] Kaparissides C, Alexandridou S, Kotti K, Chaitidou S. Recent advances in novel drug delivery systems. J Nanotech Online 2006; 2: 1-11.

[8] Harendra, S., & Vipulanandan, C. Production and Characterization of Liposome Systems for Pharmaceutical Applications, Vipulanandan Center for Innovative Grouting Material and Technology (CIGMAT), Department of Civil and Environmental Engineering University of Houston: Houston, pp. 77202–4003, 2006.

[9] Mazur, F.; Bally, M.; Städler, B.; Chandrawati, R. Liposomes and lipid bilayers in biosensors. Adv. Colloid Interface Sci. 2017, 249, 88–99. ScienceDirect

[10] Morgan, J. R., Williams, L. A., & Haward, C. B. Technetium-labelled liposome imaging for deep-seated infection. British Journal of Radiology. 1985; 58, 35–39.

[11] Woodle, M. C. Sterically stabilized liposome therapeutics. Advanced Drug Delivery Reviews. 1995; 16(2–3), 249–265.

[12] Paltauf, F., & Hermetter, A. Phospholipids — Natural, Semisynthetic, Synthetic. In I. Hanin & G. Pepeu (Eds.), Phospholipids: Biochemical, Pharmaceutical, and Analytical Considerations (pp. 1–12). Springer. 1990.

[13] Nagayasu, A., Uchiyama, K., & Kiwada, H. The size of liposomes: A factor which effects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs. Advanced Drug Delivery Reviews. 1999; 40, 75–87.

[14] Lakshmi Andra VVSN, Pammi SVN, Krishna Priya Bhatraju LV, Ruddaraju LK. A Comprehensive Review on Novel Liposomal Methodologies, Commercial Formulations, Clinical Trials and Patents. BioNanoScience. 2022; 12: 2749-291. Springer

[15] Nogueira, E.; Gomes, A.C.; Preto, A.; Cavaco-Paulo, A. Design of liposomal formulations for cell targeting. Colloids Surf. B. 2015, 136, 514–526.

[16] Kohli, A.G.; Kierstead, P.H.; Venditto, V.J.; Walsh, C.L.; Szoka, F.C. Designer lipids for drug delivery: From heads to tails. J. Control. Release 2014, 190, 274–287. ScienceDirect

[17] Li, J., Wang, X., Zhang, T., Wang, C., Huang, Z., Luo, X., & Deng, Y. (2015). A review on phospholipids and their main applications in drug delivery systems. Asian Journal of Pharmaceutical Sciences, 10(2), 81–98. ScienceDirect

[18] Sackmann, E. (1994). Membrane bending energy concept of vesicle-and cell-shapes and shape-transitions. FEBS Letters, 346(1), 3–16. PubMed

[19] Suntres, Z. E. (2011). Liposomal Antioxidants for Protection against Oxidant-Induced Damage. Journal of Toxicology, 1–16. PubMed

[20] Zhang, H. (2017). Thin film hydration followed by Extrusion Method for Liposome Preparation. Methods in Molecular Biology, 1522, 17–22. Springer

[21] Deamer, D. W. (1978). Preparation and properties of ether injection liposomes. Annals of the New York Academy of Sciences, 308, 250–258.

[22] Brunner, J., Skrabal, P., & Hauser, H. (1976). Single bilayer vesicles prepared without sonication: physico chemical properties. Biochimica et Biophysica Acta (BBA) – Biomembranes, 455(2), 322–331. ScienceDirect

[23] Yu, Bo., Lee, J Robert, & Lee, L James. (2009). Microfluidic Methods for Production of Liposomes. Methods in Enzymology., 465, 129–141. ScienceDirect

[24] Nkanga, C. I., & Krause, R. W. M. (2019). Encapsulation of Isoniazid-conjugated Phthalocyanine-In-Cyclodextrin-In-Liposomes Using Heating Method. Scientific Reports, 9, 11485. Nature

[25] Yen, T. T. H. Dan, L. N. Hoang, L. D. Tung, B. T., & Minh Hue, P. T. (2019). Preparation and characterization of freeze dried liposomes loaded with Amphotericin B. Current Drug Therapy, 14(1).

[26] Liu P, Chen G, Zhang J. A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives. Molecules. 2022; 27: 1372. MDPI

[27] Mehdi Hasan, Md., Hasan, M., Mondal, J. C., Hasan, M. A., Talukder, S., & Rashid, H. A. (2017). Liposomes: An advance tools for novel drug delivery system. The Pharma Innovation Journal, 6(11), 304–311.

[28] Bokrova, J. Marova, I. Matouskova, P. Pavelkova, R. Fabrication of novel PHB-liposome nanoparticles and study on their toxicity in vitro. Journal of Nanoparticle Research, 2019; 21(3).

[29] Ong, S. G. M., Ming, L. C., & Lee, K. S. (2016). Influence of the encapsulation efficiency and size of liposome on the oral bioavailability of griseofulvin-loaded liposomes. Pharmaceutics, 8(3), 25. MDPI

[30] Shamshiri, M. K., Jaafari, M. R., & Badiee, A. (2021). Preparation of liposomes containing IFN-gamma and their potentials in cancer immunotherapy: In vitro and in vivo studies in a colon cancer mouse model. Life Sciences, 264, 11860–11865.

[31] Azithromycin. Indian Pharmacopoeia, Vol 2, Ministry of Health and Family Welfare, Govt of India, 2007, pp 140-141.

[32] Gelen-Gungor D, Nigiz S, Ozkul C, Eroglu H, Nemutlu E, Ulubayram K, Mao Y, Michniak-Kohn B, Eroglu I. Co-delivery of azithromycin and nisin through liposomes for skin infection to reduce antimicrobial drug resistance. ScienceDirect

@article{1723712,
      author = {Poonam Vishwakarma, Dr. Sandeep Jain, Dr. Bharat K. Tyagi, Dr. Pradeep Chauhan},
      title = {DOE-based Development of Liposome Encapsulated Delivery of Azithromycin for Wound Healing},
      journal = {Iconic Research And Engineering Journals},
      year = {2026},
      volume = {10},
      number = {4},
      pages = {291-300},
      issn = {2456-8880},
      url = {https://www.irejournals.com/formatedpaper/1723712.pdf},
      abstract = {Wound healing is a complex and dynamic biological process that can be compromised by microbial infection, excessive inflammation, and delayed tissue regeneration. Azithromycin, a macrolide antibiotic, possesses broad-spectrum antibacterial activity and has also demonstrated anti-inflammatory and immunomodulatory properties that may be beneficial in wound management. However, conventional delivery of azithromycin may be limited by inadequate localization at the wound site, variable drug availability, and the need for repeated administration. Liposomal drug delivery offers a promising approach for improving the localized and sustained delivery of azithromycin while potentially enhancing its therapeutic effectiveness and reducing systemic exposure. The present study focuses on the development and optimization of azithromycin-loaded liposomes using a Design of Experiments (DOE) approach. Critical formulation variables, such as lipid-to-drug ratio, phospholipid concentration, cholesterol concentration, and process conditions, can be systematically investigated to determine their effects on critical quality attributes, including vesicle size, polydispersity index, zeta potential, encapsulation efficiency, and drug release. A suitable experimental design can be employed to identify significant formulation variables and their interactions and to establish an optimized formulation with desirable physicochemical and drug-release characteristics. The optimized liposomal formulation may subsequently be evaluated for in vitro drug release, stability, antibacterial activity, cytocompatibility, and wound-healing potential. This systematic DOE-based approach is expected to facilitate rational formulation development and provide a potential liposomal platform for localized azithromycin delivery in wound management.},
      month = {October},
  }